Data / Form D filings / Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc.: Form D filings
Convergent Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on August 13, 2024, reports $22.2 million sold of a $40 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BROADWAY, 14TH FLOOR, Cambridge, MA, 02142
- Phone
- (617) 710-4289
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1978126
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2024 | New notice | $39,999,996 | $22,222,220 | $17,777,776 | 1 | Jul 31, 2024 | sec.gov |
| May 22, 2023 | New notice | $99,170,694 | $29,170,704 | $69,999,990 | 15 | Apr 27, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Sullivan | Executive Officer | |
| Jake Simson | Director | |
| Tal Zaks | Director | |
| Jim Trenkle | Director | |
| Philip Kantoff | Executive Officer, Director | |
| Alexander Brown | Executive Officer | |
| Neil Bander | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 12, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Convergent Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.